Anika Therapeutics (ANIK) Deferred Taxes (2010 - 2026)
Anika Therapeutics' (ANIK) quarterly Deferred Taxes came in at $108000.0 in Q1 2026, up 500.0% year-on-year from $18000.0 in Q1 2025, and up 532.0% on a QoQ basis from -$25000.0 in Q4 2025.
Anika Therapeutics (ANIK) Deferred Taxes (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 16 years of Deferred Taxes data on file, last reported at $108000.0 in Q1 2026.
- On a quarterly basis, Deferred Taxes rose 500.0% year-over-year to $108000.0 in Q1 2026; TTM through Mar 2026 was $83000.0, a 2.35% decrease from a year earlier, with the FY2025 full-year figure at -$7000.0, down 102.69% from the prior year.
- Deferred Taxes for Q1 2026 stood at $108000.0, up from -$25000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for ANIK reached as high as $234000.0 in Q4 2024 and fell as low as -$2.4 million in Q1 2023.
- Historically, Deferred Taxes has averaged -$660941.2 across 5 years, with a median of -$184000.0 in 2024.
- Across the five-year window, Deferred Taxes slumped 769.23% in 2023 and soared 500.0% in 2026, its largest moves.
- Year by year, Deferred Taxes stood at -$1.8 million in 2022, then decreased by 3.6% to -$1.8 million in 2023, then jumped by 112.7% to $234000.0 in 2024, then plunged by 110.68% to -$25000.0 in 2025, then jumped by 532.0% to $108000.0 in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were $108000.0 in Q1 2026, -$25000.0 in Q4 2025, and $3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Anika Therapeutics | 198.50 Mn | 131.71 Mn | 19.00 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | -184,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | -1.84 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -904,000.00 |
| Mar 31, 2023 | -2.37 Mn |
| Dec 31, 2022 | -1.78 Mn |
| Sep 30, 2022 | -1.47 Mn |
| Jun 30, 2022 | -1.75 Mn |
| Mar 31, 2022 | -273,000.00 |
| Dec 31, 2021 | -2.78 Mn |
| Sep 30, 2021 | -178,000.00 |
| Jun 30, 2021 | 2.36 Mn |